Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I-Lin Lu

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 25, 2017
Tumortropic adipose-derived stem cells carrying smart nanotherapeutics for targeted delivery and dual-modality therapy of orthotopic glioblastomaWen-Chia Huang, I-Lin Lu, Wen-Hsuan Chiang, et al.
European Journal of Medicinal Chemistry|January 22, 2008
A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitorsI-Lin Lu, Keng-Chang Tsai, Yi-Kun Chiang, et al.
Journal of Medicinal Chemistry|June 9, 2006
Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studiesKeng-Chang Tsai, Shih-Yuan Chen, Po-Huang Liang, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2005
Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitorsI-Lin Lu, Shiow-Ju Lee, Hsu Tsu, et al.
Journal of Medicinal Chemistry|October 13, 2006
Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonistsNeeraj Mahindroo, Yi-Hui Peng, Chia-Hui Lin, et al.
Journal of Medicinal Chemistry|February 3, 2006
Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studiesNeeraj Mahindroo, Chiung-Chiu Wang, Chun-Chen Liao, et al.
Journal of Medicinal Chemistry|April 28, 2006
Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activitiesI-Lin Lu, Chien-Fu Huang, Yi-Hui Peng, et al.
Journal of Medicinal Chemistry|January 6, 2006
2-[3-[2-[(2S)-2-Cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]- 1,2,3,4-tetrahydroisoquinoline: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IVHsu Tsu, Xin Chen, Chiung-Tong Chen, et al.
Journal of Medicinal Chemistry|December 22, 2005
Novel indole-based peroxisome proliferator-activated receptor agonists: design, SAR, structural biology, and biological activitiesNeeraj Mahindroo, Chien-Fu Huang, Yi-Huei Peng, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 25, 2017
Tumortropic adipose-derived stem cells carrying smart nanotherapeutics for targeted delivery and dual-modality therapy of orthotopic glioblastomaWen-Chia Huang, I-Lin Lu, Wen-Hsuan Chiang, et al.
European Journal of Medicinal Chemistry|January 22, 2008
A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitorsI-Lin Lu, Keng-Chang Tsai, Yi-Kun Chiang, et al.
Journal of Medicinal Chemistry|June 9, 2006
Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studiesKeng-Chang Tsai, Shih-Yuan Chen, Po-Huang Liang, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2005
Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitorsI-Lin Lu, Shiow-Ju Lee, Hsu Tsu, et al.
Journal of Medicinal Chemistry|October 13, 2006
Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonistsNeeraj Mahindroo, Yi-Hui Peng, Chia-Hui Lin, et al.
Journal of Medicinal Chemistry|February 3, 2006
Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studiesNeeraj Mahindroo, Chiung-Chiu Wang, Chun-Chen Liao, et al.
Journal of Medicinal Chemistry|April 28, 2006
Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activitiesI-Lin Lu, Chien-Fu Huang, Yi-Hui Peng, et al.
Journal of Medicinal Chemistry|January 6, 2006
2-[3-[2-[(2S)-2-Cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]- 1,2,3,4-tetrahydroisoquinoline: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IVHsu Tsu, Xin Chen, Chiung-Tong Chen, et al.
Journal of Medicinal Chemistry|December 22, 2005
Novel indole-based peroxisome proliferator-activated receptor agonists: design, SAR, structural biology, and biological activitiesNeeraj Mahindroo, Chien-Fu Huang, Yi-Huei Peng, et al.
Pageof 2